Gene · 3047
Papers4,047
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 4,047
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Erythroid Cell Research: 3D Chromatin, Transcription Factors and Beyond. | Int J Mol Sci | 2022 | 35682828 | PubTator, text mining | PubMed |
| Acrylamide and Potential Risk of Diabetes Mellitus: Effects on Human Population, Glucose Metabolism and Beta-Cell Toxicity. | Int J Mol Sci | 2022 | 35682790 | PubTator, text mining | PubMed |
| Hematopoietic Stem Cell Gene-Addition/Editing Therapy in Sickle Cell Disease. | Cells | 2022 | 35681538 | PubTator, text mining | PubMed |
| In vivo HSC transduction in rhesus macaques with an HDAd5/3+ vector targeting desmoglein 2 and transiently overexpressing cxcr4. | Blood Adv | 2022 | 35679480 | PubTator, text mining | PubMed |
| Functional foods: promising therapeutics for Nigerian Children with sickle cell diseases. | Heliyon | 2022 | 35677416 | PubTator, text mining | PubMed |
| PUM1 mediates the posttranscriptional regulation of human fetal hemoglobin. | Blood Adv | 2022 | 35667093 | PubTator, text mining | PubMed |
| Structural Insight into Terminal Galactose Recognition by Two Non-HBGA Binding GI.3 Noroviruses. | J Virol | 2022 | 35658530 | PubTator, text mining | PubMed |
| Induction of Fetal Hemoglobin by Introducing Natural Hereditary Persistence of Fetal Hemoglobin Mutations in the γ-Globin Gene Promoters for Genome Editing Therapies for β-Thalassemia. | Front Genet | 2022 | 35656314 | PubTator, text mining | PubMed |
| Salubrinal induces fetal hemoglobin expression via the stress-signaling pathway in human sickle erythroid progenitors and sickle cell disease mice. | PLoS One | 2022 | 35639781 | PubTator, text mining | PubMed |
| High-level correction of the sickle mutation is amplified in vivo during erythroid differentiation. | iScience | 2022 | 35633935 | PubTator, text mining | PubMed |
| Frequent Occurrence of Simultaneous Infection with Multiple Rotaviruses in Swiss Pigs. | Viruses | 2022 | 35632858 | PubTator, text mining | PubMed |
| Rotaviruses: From Pathogenesis to Disease Control-A Critical Review. | Viruses | 2022 | 35632617 | PubTator, text mining | PubMed |
| Targeting the Hematopoietic Stem Cell Niche in β-Thalassemia and Sickle Cell Disease. | Pharmaceuticals (Basel) | 2022 | 35631417 | PubTator, text mining | PubMed |
| Tissue-Specific Variations in Transcription Factors Elucidate Complex Immune System Regulation. | Genes (Basel) | 2022 | 35627314 | PubTator, text mining | PubMed |
| Morbid Obesity in Women Is Associated with an Altered Intestinal Expression of Genes Related to Cancer Risk and Immune, Defensive, and Antimicrobial Response. | Biomedicines | 2022 | 35625760 | PubTator, text mining | PubMed |
| Identification and characterization of RBM12 as a novel regulator of fetal hemoglobin expression. | Blood Adv | 2022 | 35622975 | PubTator, text mining | PubMed |
| Dual function NFI factors control fetal hemoglobin silencing in adult erythroid cells. | Nat Genet | 2022 | 35618846 | PubTator, text mining | PubMed |
| Tenofovir disoproxil fumarate-mediated γ-globin induction is correlated with the suppression of trans-acting factors in CD34+ progenitor cells: A role in the reactivation of fetal hemoglobin. | Eur J Pharmacol | 2022 | 35618038 | PubTator, text mining | PubMed |
| A preliminary, observational study using whole-blood RNA sequencing reveals differential expression of inflammatory and bone markers post-implantation of percutaneous osseointegrated prostheses. | PLoS One | 2022 | 35617338 | PubTator, text mining | PubMed |
| 6,7-Dimethoxycoumarin Influences the Erythroid Differentiation of Human Chronic Myelogenous Leukemia K562 Cells through Regulating FOXO3/p27 Signal Pathway. | J Oncol | 2022 | 35607323 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3047/papers?page=34